Completed PHASE3 INTERVENTIONAL NCT00495690

Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease

Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Mortality and Severe Disease Requiring Hospitalization

Sponsor: Indian Council of Medical Research

Conditions Death Diarrhea Meningitis Pneumonia Sepsis

Interventions Oral zinc gluconate (5 mg elemental)

Updated 5 times since 2017 Last updated: Sep 14, 2011 Started: Nov 30, 2004 Primary completion: Nov 30, 2007 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Death and Diarrhea and is currently completed. Indian Council of Medical Research leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indian Council of Medical Research
Society for Applied Studies

Data source: Society for Applied Studies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kolkata, India